Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 48973 questions Show Answers
To ask the Scottish Government what its response is to reported warnings from several national supermarkets regarding an increase in shoplifting.
To ask the Scottish Government whether it can provide figures on how many post-mortem examinations conducted under the instruction of the Crown Office and Procurator Fiscal Service (COPFS) since 1 January 2023 have involved the removal of the brain.
To ask the Scottish Government how many dog attacks have resulted in hospitalisation in the last five years, broken down by dog breed.
To ask the Scottish Government whether Rimegepant will be made available as a treatment option for acute migraine, in accordance with the National Institute for Health and Care Excellence (NICE) guidance.
To ask the Scottish Government what action it is taking to promote awareness of migraine disorders during Migraine Awareness Week 2023.
To ask the Scottish Government whether it plans to consult further on the proposed Agriculture Bill with expert farmers groups and environmental non-governmental organisations.
To ask the Scottish Government how it will support collaborative and integrated land management under the proposed Agriculture Bill, including whether it will include such measures in the Bill.
To ask the Scottish Government what its position is on whether the four-tiered payment structure of the proposed Agriculture Bill represents value for money.
To ask the Scottish Government whether it has any plans to update its Partnership Information Network (PIN) policies in partnership with NHS Scotland employers.
To ask the Scottish Government what plans it has to improve awareness of the COVID-19 post-exposure treatments available to people at high risk, and of how people can access such treatments.